Research output per year
Research output per year
Personal profile
Research interests
Rare rheumatic disease
COVID-19 and rheumatic diseases
Biological disease modified antirheumatic drugs
External positions
Pauls Stradins Clinical University hospital
10 Oct 2006 → …
Field of Science
- 3.2 Clinical medicine
- 3.3 Health sciences
Keywords
- Rheumatology
- Rare rheumatic diseases
Fingerprint
Dive into the research topics where Inita Buliņa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
Putman, M., Kennedy, K., Sirotich, E., COVID-19 Global Rheumatology Alliance & Bulina, I., Apr 2022, In: The Lancet Rheumatology. 4, 4, p. e237-e240Research output: Contribution to journal › Comment/debate
Open Access2 Citations (Scopus) -
SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: Results from the COVID-19 Global Rheumatology Alliance provider registry
Liew, J., Gianfrancesco, M., Harrison, C., Izadi, Z., Rush, S., Lawson-Tovey, S., Jacobsohn, L., Ja, C., Hyrich, K. L., Gossec, L., Strangfeld, A., Carmona, L., Schafer, M., Frazao-Mateus, E., Bulina, I., Stafford, F., Tufan, A., Graver, C., Yardlmcl, G. K., Zepa, J. & 25 others, , 6 Apr 2022, In: RMD Open. 8, 1, e002187.Research output: Contribution to journal › Article › peer-review
Open Access -
Association between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death among Patients with Immune-Mediated Inflammatory Disease and COVID-19
Izadi, Z., Brenner, E. J., Psoriasis Patient Registry Outcome, Secure Epidemiology of Coronavirus Under Research Exclusion for Inflammatory Bowel Disease (SECURE-IBD), COVID-19 Global Rheumatology Alliance, Zepa, J. & Buliņa, I., Oct 2021, In: JAMA network open. 4, 10, e2129639.Research output: Contribution to journal › Article › peer-review
Open AccessFile11 Citations (Scopus) -
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
Sparks, J. A., COVID-19 Global Rheumatology Alliance, Zepa, J. & Buliņa, I., 1 Sep 2021, In: Annals of the Rheumatic Diseases. 80, 9, p. 1137-1146 10 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile44 Citations (Scopus)1 Downloads (Pure) -
Characteristics of PCR confirmed COVID-19 cases in patients with autoimmune rheumatic diseases in Latvia
Buliņa, I., Kadiša, A. & Zepa, J., 24 Mar 2021, p. 488.Research output: Contribution to conference › Abstract › peer-review
Activities
-
RSU Research week 2021: Knowledge for Use in Practice (Event)
Inita Buliņa (Reviewer of conference paper)
24 Mar 2021Activity: Publication peer-review and editorial work types › Publication Peer-review
-
Characteristics of PCR confirmed COVID-19 cases in patients with autoimmune rheumatic diseases in Latvia
Inita Buliņa (Speaker)
24 Mar 2021Activity: Talk or presentation types › Poster presentation
-
European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal Diseases (External organisation)
Inita Buliņa (Expert)
2018 → …Activity: Membership types › Membership of network
-
Latvian Society of Adult Rheumatology (External organisation)
Inita Buliņa (Member)
2016 → …Activity: Membership types › Membership of NGOs
Press / Media
-
Labākai veselībai un ilgākam mūžam
Ilze Konrāde, Vita Skuja & Inita Buliņa
1/12/20
1 item of Media coverage
Press/Media